{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-001101","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2023-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.237585+00:00","generated_at":"2026-06-10T05:10:48.448171+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NYSE American warns China Pharma of delisting; avg price below $0.20, cure by March 2024","bullets":["On Sep 27, 2023, NYSE American notified CPHI of noncompliance: 30-day avg stock price below $0.20.","Company must effect a reverse stock split or demonstrate sustained price improvement by Mar 27, 2024.","Continues to address prior stockholders' equity noncompliance from June 2022.","Listing remains on NYSE American during cure period; business operations unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-001101","json":"https://secwatch.observer/filing/0001013762-23-001101.json","markdown":"https://secwatch.observer/filing/0001013762-23-001101.md","text":"https://secwatch.observer/filing/0001013762-23-001101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/0001013762-23-001101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/ea186256-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:10:48.448171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}